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Cardiac resynchronisation therapy (CRT) is increasingly
being used to treat or prevent heart failure in patients with
intraventricular or atrioventricular conduction delay. Due to
improved implantation tools and improved electrode design,
implantation failure rates have decreased in recent years
from 5–10% to less than 4%, questioning the need for pre-
implantation imaging [1]. The introduction of quadripolar
leads in particular has led to reduction of implant failures
and the need for reoperation due to left ventricular lead
failure, as has been shown by randomised comparison of
bipolar to quadripolar leads [1].
The success of CRT, however, not only depends on suc-
cessful implantation but also on several other factors includ-
ing left ventricular lead position. To predict the optimal im-
plantation site for left ventricular electrodes and to assess
availability of target veins in this optimal region, cardiac
imaging can be particularly useful.
In this issue of the Netherlands Heart Journal, Nguyên
et al. describe their protocol employing computed tomogra-
phy angiography (CTA) to visualise coronary sinus anatomy
prior to CRT implantation [2]. On the one hand, it is im-
portant to use a special protocol for the visualisation of
coronary veins in patients with heart failure, as it takes
longer for contrast medium to travel to the coronary ve-
nous system. On the other hand, many patients with heart
failure also have impaired renal function, which limits the
use of large amounts of contrast medium. With the protocol
described by Nguyên et al., there was a high concordance
(85%) between CTA and fluoroscopic coronary venogram
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during implantation. Several veins were only visible during
CTA (10%), whereas others were only visible at implant
fluoroscopy (5%), demonstrating the additive value of both
techniques.
There are several techniques to visualise coronary ve-
nous anatomy before implantation. Fluoroscopic imaging of
the coronary sinus can be done as a stand-alone procedure
but due to the invasive nature of this technique it is usu-
ally deferred to the implantation procedure. The caveat of
intra-procedural imaging, however, is that an unfavourable
anatomy is first discovered during implantation and addi-
tional technical resources to overcome the difficulties may
not be available. A relatively easy technique to visualise
coronary venous anatomy is the venous phase of coronary
angiograms. In the work-up of patients with heart failure,
coronary angiograms are often performed to rule out un-
derlying coronary artery disease and interventional cardi-
ologists should be aware that the venous phase visualises
coronary veins without the need of extra contrast medium
and with little increase in radiation exposure of the patient.
It has been shown that the information gained from previ-
ous coronary angiograms is comparable with retrograde flu-
oroscopy and in some cases implantation can be performed
without additional intra-procedural imaging [3]. CTA as de-
scribed by Nguyên et al. is a non-invasive technique that not
only supports the visualisation of infarcted areas but also
demonstrates the anatomy of the phrenic nerve in relation
to possible target veins [4]. Despite the incremental radi-
ation exposure, CTA should be considered in all patients,
especially in patients with prior myocardial infarction and
in patients who did not have a venous phase coronary an-
giogram.
Unfortunately, not all areas of pre-procedural imaging
can be covered by CTA and we need additional imaging
techniques (as summarised in Fig. 1). For CRT patient se-
lection, we need to assess left ventricular ejection fraction
by echocardiogram or magnetic resonance imaging (MRI).
These techniques have the advantage that they can also be
used to identify myocardial scar and the area of latest me-
chanical activation. It has been shown in randomised trials
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Fig. 1 Flow diagram of imaging options before and after CRT implan-
tation. CTA computed tomography angiography; MRI magnetic reso-
nance imaging; LVEF left ventricular ejection fraction; CAG coronary
angiogram; CRT cardiac resynchronisation therapy
that placing the left ventricular lead in the area of latest me-
chanical activation (out of scar) improves response rates to
CRT and reduces hard clinical end points [5, 6]. In a perfect
world, imaging would incorporate both venous anatomy and
the ‘sweet spot’ for implantation showing the optimal target
vein for implantation. Current studies are ongoing incorpo-
rating MRI information into intra-procedural fluoroscopy to
guide implantation to the optimal myocardial area [7].
What should be done if pre-implantation imaging shows
an unfavourable anatomy? Nguyên et al. have abandoned
CRT implantation due to absence of a suitable target vein
and changed the implantation strategy to a right-sided im-
plant in two patients with persistent left-sided superior vena
cava. If there is a class I indication for CRT, there are sev-
eral alternative options for implantation. Left ventricular
endocardial implantation is technically feasible and effec-
tive but carries a high risk of systemic thromboembolism
even in patients using anticoagulation [8]. A safe alternative
is the more invasive technique of epicardial left ventricular
lead placement that in the hands of experienced thoracic
surgeons can be done successfully with video-assisted tho-
racoscopic surgery [9].
Imaging does not stop at CRT implantation as shown
in Fig. 1. Echocardiography should be used to determine
the amount of reverse ventricular remodelling. It has been
shown that the amount of reverse remodelling can be pre-
dicted by the relatively simple MARC score which incor-
porates indices of electrical and mechanical dyssynchrony
[10]. Reverse remodelling predicts clinical outcome. In pa-
tients with suboptimal CRT response, additional measures
might be taken to assess possibilities for improvement [11].
Even though atrioventricular interval optimisation has not
been shown to improve CRT response, it could be effec-
tive in sub-optimal responders. Atrial remodelling has been
shown to affect clinical outcome and is a possible target
of atrioventricular interval optimisation [12]. It should also
be investigated if the left ventricular lead has actually been
placed in or near the area of latest mechanical activation.
When using a quadripolar lead, the activation of multi-site
pacing could be considered to improve reverse remodelling.
Pre-implantation as well as post-implantation cardiac
imaging is crucial to optimise the response to CRT. We
will see accumulating data that incorporate multi-modal-
ity cardiac imaging into implantation protocols to identify
the optimal left ventricular pacing site. Implanting might
become easier if good imaging techniques have been em-
ployed but CRT pathways in implanting centres need to
incorporate alternative implantation strategies in patients
with unfavourable venous anatomy.
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